Akebia Therapeutics Inc’s filing revealed that its CEO and President Butler John P. unloaded Company’s shares for reported $0.3 million on Feb 03 ’25. In the deal valued at $2.10 per share,144,250 shares were sold. As a result of this transaction, Butler John P. now holds 2,604,330 shares worth roughly $ 5.39 million.
Then, Burke Steven Keith sold 50,506 shares, generating $106,063 in total proceeds. Upon selling the shares at $2.10, the SVP, Chief Medical Officer now owns 816,234 shares.
Before that, Malabre Richard C sold 30,202 shares. Akebia Therapeutics Inc shares valued at $63,424 were divested by the SVP, Chief Accounting Officer at a price of $2.10 per share. As a result of the transaction, Malabre Richard C now holds 280,248 shares, worth roughly $0.58 million.
A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who increased its forecast for the stock in late August from “a Neutral” to “a Buy”. Piper Sandler also remained covering AKBA and has increased its forecast on May 31, 2023 with a “an Overweight” recommendation from previously “Neutral” rating. Piper Sandler revised its rating on March 31, 2022. It rated AKBA as “a Neutral” which previously was an “an Overweight”.
Price Performance Review of AKBA
On Tuesday, Akebia Therapeutics Inc [NASDAQ:AKBA] saw its stock fall -2.82% to $2.07. Over the last five days, the stock has lost -1.43%. Akebia Therapeutics Inc shares have risen nearly 8.95% since the year began. Nevertheless, the stocks have risen 35.29% over the past one year. While a 52-week high of $2.48 was reached on 01/27/25, a 52-week low of $0.80 was recorded on 01/13/25. SMA at 50 days reached $2.03, while 200 days put it at $1.54.
Levels Of Support And Resistance For AKBA Stock
The 24-hour chart illustrates a support level at 2.05, which if violated will result in even more drops to 2.02. On the upside, there is a resistance level at 2.12. A further resistance level may holdings at 2.16. The Relative Strength Index (RSI) on the 14-day chart is 45.77, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.05, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 100.00%. Stochastics %K at 21.15% indicates the stock is a holding.
